Friday, July 10, 2026

pharma · Multiple Myeloma · Ovarian Cancer

pharma&

pharma& trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Vienna, AT HQ
2017 Founded
210 Employees
EMA registrant Type
Company details
Intelligence · Clinical Trials

pharma& clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to pharma& programs — each row shows trial ID, program name, phase, status, and indication.

pharma& trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for pharma&.

  1. CO-338-087 — Phase 3

    Clinical update
  2. Panobinostat Capsules — Phase 2

    Clinical update
  3. Rucaparib — Phase 3

    Clinical update

Trial registry

3 studies
  1. 2024-516662-11-00

    CO-338-087

    Phase 3 active small_molecule

    Ovarian epithelial cancer, Malignant peritoneal neoplasm, advanced (FIGO stage III-IV), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (who responded to front-line platinum-based chemotherapy), Fallopian tube cancer

    CTIS ↗